These data implicate β2AR in the modulation of mitochondrial metabolic activity and disease progression in HPV( + ) HNSCC, and identify β2AR as a potential therapeutic target, particularly in the recurrent/metastatic setting where effective treatment options are limited. The gene discussed is ADRB2; the disease is head and neck squamous cell carcinoma.